MGPI MGP Ingredients
MGP Ingredients earnings company data as of 4:45 AM ET 10/15
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | 0.34 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by MGPI's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $11M sold by 4 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Leslie Lux 10% owner, +1 joint filerSale$399K 27,731 shares at $14.40 100% of stakeTraded Sep 16 Filed Sep 18
-
Paul S. Lux 10% ownerSale$586K 33,000 shares at $17.76 5.7% of stakeTraded Aug 20 Filed Aug 24
-
Caroline Lux Kaplan 10% ownerSale$1.1M 60,000 shares at $18.00 11% of stakeTraded May 26–27 Filed May 28
-
Karen Seaberg DirectorSale$7.5M 304,535 shares at $24.66 90% of stakeTraded Dec 8–10 Filed Dec 10, 2025
-
Caroline Lux Kaplan 10% ownerSale$1.4M 60,000 shares at $23.56 10% of stakeTraded Nov 18–19 Filed Nov 20, 2025
Also filed in the last 12 months, not counted as buying or selling: 19 stock grants and 10 share withholdings for taxes.
SEC filings
Recent issuer filings from EDGAR, 16 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 5.03,7.01,9.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.07,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.